Investors & Media

Corporate Profile

Aura Biosciences is leveraging a novel targeted oncology platform to develop a potential new standard of care across multiple cancer indications, with an initial focus on ocular and urologic oncology.

 


Recent Financial Filings

Filing date Form Filing Group
10-Q
Quarterly Filings
8-K
Current Reports
ARS
Annual Filings

Stock Information

AURA BIOSCIENCES


May 30, 2024 9:29 AM EDT
Data Provided by Refinitiv. Minimum 15 minutes delayed.